Atlas Trials

Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer

Clinical trial NCT04033419 · COMPLETED

Trial details

NCT number
NCT04033419
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cognitive DeclineChemo-brain
Start date
2019-09-25
Primary completion
2022-04-04
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.